Delusional phenomenology--dimensions of change. by Sharp, H, Fear, C, Williams, J, Healy, D, Lowe, C, Yeadon, H, Holden, R

Managing schizophrenia in primary care: The utility of remission criteria as outcome indicators by Fear, C, Yeomans, D, Moore, B, Taylor, M, Ford, K, Currie, A, Hynes, J, Sullivan, G, Whale, R, Burns, T

Resolution and remission in schizophrenia: Getting well and staying well by Yeomans, D, Taylor, M, Currie, A, Whale, R, Ford, K, Fear, C, Hynes, J, Sullivan, G, Moore, B, Burns, T

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 by Brevini, T, Maes, M, Webb, GJ, John, BV, Fuchs, CD, Buescher, G, Wang, L, Griffiths, C, Brown, ML, Scott, WE, Pereyra-Gerber, P, Gelson, WTH, Brown, S, Dillon, S, Muraro, D, Sharp, J, Neary, M, Box, H, Tatham, L, Stewart, J, Curley, P, Pertinez, H, Forrest, S, Mlcochova, P, Varankar, SS, Darvish-Damavandi, M, Mulcahy, VL, Kuc, RE, Williams, TL, Heslop, JA, Rossetti, D, Tysoe, OC, Galanakis, V, Vila-Gonzalez, M, Crozier, TWM, Bargehr, J, Sinha, S, Upponi, SS, Fear, C, Swift, L, Saeb-Parsy, K, Davies, SE, Wester, A, Hagström, H, Melum, E, Clements, D, Humphreys, P, Herriott, J, Kijak, E, Cox, H, Marjot, T, Barnes, E, Buczacki, SJA